After the books closed: the quarter's biggest news happened too late to be in the numbers
The model's full reasoning — Q4 2016 call → NOThe question asks whether management reports that the most important positive developments happened so late in the period or shortly after it ended that the results contain little or none of their effect, with management marking the timing. Let me examine the transcript for evidence of this pattern. Key developments mentioned: 1. The acquisition of Inderal LA (April 2016) - this was during the year 2. The acquisition of Inderal XL and InnoPran XL - this was after the quarter ended (the call is March 2, 2017, and the acquisition was announced "last week" per Steve Carey) 3. The termination of the HPC distribution agreement in Q4 4. Corticotropin project progress Let me look at the specific timing language: Steve Carey says: "As announced and disclosed last week, we utilized cash on hand along with $30 million of borrowings from our credit agreement with Citizens Bank to fund the purchase of two brand products, InnoPran XL and Inderal XL for total consideration of approximately $51 million." So the InnoPran XL and Inderal XL acquisition happened after the quarter ended (in late February 2017, "last week" from the March 2 call). Art Przybyl says: "Recently, we acquired and launched Inderal XL and InnoPran XL, two products that will help brand drug revenue continue to grow in 2017." And: "Obviously, we just launched the two products that we acquired on the next day after we acquired the products. Inderal XL and InnoPran XL." So these were acquired and launched after the quarter ended, and they are described as helping brand drug revenue grow in 2017. Now, does management treat these as "the real story the numbers missed"? Let me check. The guidance for 2017 includes these products. Steve Carey says: "We currently anticipate strong growth in our key financial metrics driven by the annualization and continued operational focus on maximizing 2016 launches, expansion of our brand revenues with the addition of InnoPran XL and Inderal XL..." So the 2017 guidance explicitly includes the contribution from these products. But does management say the Q4 results contain little or none of their effect? The Q4 results were reported before these acquisitions. The acquisitions happened in late February 2017, after the December 31, 2016 period end. Let me check if management explicitly marks this timing.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| SWBI | Smith & Wesson Brands, Inc. | Q1 2023 | 2022-09-08 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
OPK · Q1 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management treating the ModeX acquisition (announced and closed on the call date, May 9) and the Sema4/GeneDx deal (closed April 29) as major positive developments that occurred after the Q1 period ended. These are framed as key steps toward unlocking value and are highlighted as the "exciting announcement" that changed the call format.
RNW · Q2 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management explicitly marking the timing of key positive developments: 400 MW commissioned "since the end of the quarter" (bringing operating capacity to 7 GW today, with another 400 MW scheduled "over the next couple of weeks"), plus the completed Telangana acquisition adding 260 MW.
ASM · Q4 2023 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...